Previous Article | Next Article 
Infection and Immunity, September 2001, p. 5456-5463, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5456-5463.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Genetic Immunization with the Region Encoding the
-Helical Domain of PspA Elicits Protective Immunity against
Streptococcus pneumoniae
Joseph R.
Bosarge,1
James M.
Watt,2
D. Olga
McDaniel,3,4
Edwin
Swiatlo,2 and
Larry S.
McDaniel1,2,3,*
Departments of
Microbiology,1
Surgery,3
Medicine,2 and
Neurology,4 The University of
Mississippi Medical Center, Jackson, Mississippi 39216
Received 12 March 2001/Returned for modification 7 May
2001/Accepted 5 June 2001
Pneumococcal surface protein A (PspA) is a pneumococcal virulence
factor capable of eliciting protection against pneumococcal infection
in mice. Previous studies have demonstrated that the protection is
antibody mediated. Here we examined the ability of
pspA to elicit a protective immune response
following genetic immunization of mice. Mice were immunized by
intramuscular injections with a eukaryotic expression vector encoding
the
-helical domain of PspA/Rx1. Immunization induced a
PspA-specific serum antibody response, and immunized mice survived
pneumococcal challenge. Survival and antibody responses occurred in a
dose-dependent manner, the highest survival rates being seen with doses
of 10 µg or greater. The ability of genetic immunization to elicit
cross-protection was demonstrated by the survival of immunized mice
challenged with pneumococcal strains differing in capsule and PspA
types. Also, immunized mice were protected from intravenous and
intratracheal challenges with pneumococci. Similar to the results seen
with immunization with PspA, the survival of mice genetically immunized with pspA was antibody mediated. There was no decline in
the level of protection 7 months after immunization. These results
support the use of genetic immunization to elicit protective immune
responses against extracellular pathogens.
*
Corresponding author. Mailing address: The University
of Mississippi Medical Center, Department of Microbiology, 2500 North State St., Jackson, MS 39216. Phone: (601) 984-6880. Fax: (601) 984-1708. E-mail: LMcDaniel{at}microbio.umsmed.edu.
Infection and Immunity, September 2001, p. 5456-5463, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5456-5463.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ferreira, D. M., Darrieux, M., Oliveira, M. L. S., Leite, L. C. C., Miyaji, E. N.
(2008). Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production. CVI
15: 499-505
[Abstract]
[Full Text]
-
Moore, Q. C. III, Johnson, L., Repka, M., McDaniel, L. S.
(2007). Immunization with PspA Incorporated into a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae. CVI
14: 789-791
[Abstract]
[Full Text]
-
Quin, L. R., Moore, Q. C. III, McDaniel, L. S.
(2007). Pneumolysin, PspA, and PspC Contribute to Pneumococcal Evasion of Early Innate Immune Responses during Bacteremia in Mice. Infect. Immun.
75: 2067-2070
[Abstract]
[Full Text]
-
Pimenta, F. C., Ribeiro-Dias, F., Brandileone, M. C. C., Miyaji, E. N., Leite, L. C. C., Sgambatti de Andrade, A. L. S.
(2006). Genetic Diversity of PspA Types among Nasopharyngeal Isolates Collected during an Ongoing Surveillance Study of Children in Brazil.. J. Clin. Microbiol.
44: 2838-2843
[Abstract]
[Full Text]
-
Ferreira, D. M., Miyaji, E. N., Oliveira, M. L. S., Darrieux, M., Areas, A. P. M., Ho, P. L., Leite, L. C. C.
(2006). DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein.. J Med Microbiol
55: 375-378
[Abstract]
[Full Text]
-
Garcia-Suarez, M. d. M., Cima-Cabal, M. D., Florez, N., Garcia, P., Cernuda-Cernuda, R., Astudillo, A., Vazquez, F., De Los Toyos, J. R., Mendez, F. J.
(2004). Protection against Pneumococcal Pneumonia in Mice by Monoclonal Antibodies to Pneumolysin. Infect. Immun.
72: 4534-4540
[Abstract]
[Full Text]
-
Rush, C., Mitchell, T., Garside, P.
(2002). Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways. J. Immunol.
169: 4951-4960
[Abstract]
[Full Text]
-
Miyaji, E. N., Ferreira, D. M., Lopes, A. P. Y., Brandileone, M. C. C., Dias, W. O., Leite, L. C. C.
(2002). Analysis of Serum Cross-Reactivity and Cross-Protection Elicited by Immunization with DNA Vaccines against Streptococcus pneumoniae Expressing PspA Fragments from Different Clades. Infect. Immun.
70: 5086-5090
[Abstract]
[Full Text]